A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

Summary

IPM 018 is a double-blind, randomized, placebo-controlled study conducted at one site in Belgium among 24 healthy, HIV-negative women to evaluate dapivirine release for 28 days from matrix and reservoir intravaginal rings, each containing 25 mg of dapivirine, and to assess safety and tolerability compared to placebo

Timeline

Start

2007-05

Primary completion

—

Completion

2007-08

Drugs

Indications